...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Resverlogix Confirms Significant Corporate Advancement Establishing Apabetalone as Potential Blockbuster Combo Drug in High-risk Diabetics with CVD

I see this PR announcing to Merck and Eli Lilly,... that there is now competition as to who will do a deal first and get their combo treatment to market first.

Share
New Message
Please login to post a reply